MYCN and neuroblastoma: Overall, our findings support a novel mechanism for MYCN-amplified neuroblastoma where high free MYCN (i.e., not bound to MAX) directly bind to p53 and alter p53 transcriptional responses that may alter the tumor responses to genotoxic chemotherapy (Figure 7).